Biotech · Private company · Wauwatosa, WI, US
Retham Technologies, Inc.
Track this companyFree. Adds Retham Technologies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- An in vitro diagnostic assay for the early and accurate detection of platelet-activating antibodies associated with Heparin-inducedThrombocytopeniaFiscal year 2026 · $1.7MNIH RePORTER 5R44HL147734-05 · fetched Nov 12, 2026
- An in vitro diagnostic assay for the early and accurate detection of platelet-activating antibodies associated with Heparin-inducedThrombocytopeniaFiscal year 2025 · $1.2MNIH RePORTER 2R44HL147734-04 · fetched Nov 12, 2026
- An in vitro diagnostic assay for the early and accurate detection of platelet-activating antibodies associated with Heparin-induced ThrombocytopeniaFiscal year 2024 · $49.4KNIH RePORTER 3R44HL147734-03S1 · fetched Nov 12, 2026